QS Investors, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2021$588,000
-85.8%
8,815
-76.4%
0.01%
-85.4%
Q1 2021$4,147,000
-6.7%
37,353
-0.2%
0.05%
-9.4%
Q4 2020$4,446,000
+35.7%
37,443
-0.3%
0.05%
+20.5%
Q3 2020$3,277,000
-52.1%
37,548
-50.9%
0.04%
-53.7%
Q2 2020$6,847,000
-42.5%
76,448
-36.0%
0.10%
-50.0%
Q1 2020$11,906,000
-13.5%
119,460
+0.1%
0.19%
+37.7%
Q4 2019$13,759,000
-9.2%
119,360
-0.6%
0.14%
-16.4%
Q3 2019$15,146,000
+4.8%
120,0700.0%0.16%
+5.8%
Q2 2019$14,450,000
+162.8%
120,070
+91.1%
0.16%
+160.0%
Q1 2019$5,498,000
+20.2%
62,840
+37.5%
0.06%
+1.7%
Q4 2018$4,574,000
-12.7%
45,7100.0%0.06%
+18.0%
Q3 2018$5,237,000
+4123.4%
45,710
+3205.1%
0.05%
+4900.0%
Q2 2018$124,000
+22.8%
1,383
+0.4%
0.00%0.0%
Q1 2018$101,000
+26.2%
1,3770.0%0.00%0.0%
Q4 2017$80,000
+37.9%
1,377
+5.9%
0.00%
Q3 2017$58,000
+13.7%
1,3000.0%0.00%
Q2 2017$51,000
-3.8%
1,3000.0%0.00%
Q1 2017$53,000
+5200.0%
1,300
+8566.7%
0.00%
Q2 2016$1,0000.0%15
+87.5%
0.00%
Q1 2016$1,0000.0%80.0%0.00%
Q4 2015$1,00080.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders